Navigation Links
Mission Pharmacal Acquires Eletone Cream from Ferndale Healthcare, Inc.
Date:2/3/2012

SAN ANTONIO, Feb. 3, 2012 /PRNewswire/ -- Mission Pharmacal Company recently acquired the prescription barrier cream Eletone® Cream, from Ferndale Healthcare, Inc. of Ferndale, Michigan.  Eletone Cream is a non-steroidal, barrier cream approved by the Food and Drug Administration for the long term treatment of atopic dermatitis, an inflammatory, chronically relapsing, non-contagious and pruritic or itchy skin disorder.

While the addition of Eletone Cream will strengthen Mission's pediatric product offerings, it also enhances the company's targeted expansion in the dermatology market.  To augment and support its sales efforts, Mission has also created a dermatology focused sales team.  In addition to promoting Eletone, this team will be promoting and selling three other dermatology products, Ovace®, Avar®, and Texacort®.  This new team was launched through Alamo Pharma Services, a recently introduced wholly owned subsidiary of Mission Pharmacal, established to provide increased operational and human resources support. 

"Mission Pharmacal's recent advancements in dermatology and pediatrics provide a perfect platform for the promotion of Eletone Cream," states Terry Herring, president of Mission Pharmacal's Commercial Operations.  "This product has an established market share and solid brand identity.  Our intention is to use the Mission dermatology sales team to support this and other dermatology focused products over time."

"From a pure business perspective, the strategic acquisition of Eletone Cream demonstrates Mission's commitment to our core therapeutic areas," notes Neill Walsdorf, Jr., president of Mission Pharmacal Company.  "It adds a product that can be promoted by both our pediatric and dermatology sales teams."

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more tha
'/>"/>

SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Game Commission Announces EHD Confirmed in Fayette County
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)...  Breg, Inc., a premier provider of sports ... knee brace with new innovations to help people, ... to active lifestyles.  FreeRunner,s patent-pending design acts on ... when patients need it most, and the ability ... Patellofemoral issues are the most common cause of ...
(Date:7/10/2014)... July 10, 2014 Yesterday, former Congressman ... medical device manufacturing facility. Rep. Kennedy and ... monitors facilitate cutting-edge research in neurological disease and ... mental health advocate, Garen Staglin , created ... fostering fundamental changes that will radically accelerate the ...
(Date:7/10/2014)... July 10, 2014   Ventana Medical Systems, Inc. ... it has entered into an agreement with Merck KGaA, ... EMD Serono in the United States ... with Merck KGaA,s biopharmaceutical division on the development and ... target using Ventana,s proprietary diagnostic assays. In alignment with ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... 2010 VIVUS, Inc. (Nasdaq: VVUS ... of novel therapeutic products, today reported its financial results for ... Third Quarter HighlightsOn September 21, 2010, ... which showed significant and sustained weight loss of greater than ...
... Health, Inc. (Nasdaq: GHDX ) today reported financial results ... Total revenue increased to $46.3 million in the third quarter ... 2009.  Product revenue was $45.8 million in the third quarter of ... the third quarter of 2009. Net income was ...
Cached Medicine Technology:VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results 2VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results 3VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results 4VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results 5VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results 6Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 2Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 3Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 4Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 5Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 6Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 7Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 8
(Date:7/13/2014)... (PRWEB) July 13, 2014 MarketsandMarkets ... Market [3D Modeling; 3D Scanning; 3D rendering; Layout ... and Analysis (2013 - 2018)”, which analyzes and ... in North America, Western Europe, Eastern Europe, Middle ... report also draws the competitive landscape of the ...
(Date:7/13/2014)... 2014 The Pearland, Texas location of The ... from four months to 12 years of age that offers ... birthday parties and Summer Camps, is now under new ownership. ... Pearland after spending over six years at The Little ... Director. , Berry has over ten years of experience ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special ... new range of gorgeous Quinceanera dresses . ... for elegant Quinceanera outfits is huge. Therefore, 2014QuinceaneraDresses.com ... the company’s newly released dresses are made according ... elegant and vivid. , It is worthy ...
(Date:7/13/2014)... is popular among worldwide women. Its lace wedding gowns ... company has announced its new selection of elegant ... outfits are available at discounted prices (from 25 to ... now offering similar discounts for many other wonderful items. ... designs for sale, including flower girl dresses, wedding dresses, ...
(Date:7/13/2014)... July 13, 2014 A decreased ability to ... impairment and Alzheimer,s disease, while examinations of the ... protein associated with Alzheimer,s, in the brain, according ... today at the Alzheimer,s Association International Conference 2014 ... the studies, the decreased ability to identify odors ...
Breaking Medicine News(10 mins):Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7
... 2009: After five years of receiving infliximab (IFX) anti-TNF ... substantial clinical benefit (ASAS40, ASsessment in AS, 40-response) and ... 78.4% of AS patients had no arthritis and 84.9% ... and bone). Over this period, patients continued to show ...
... The board of directors of Abbott today declared a quarterly common dividend ... 342nd consecutive quarterly dividend to be paid by Abbott since 1924. ... at the close of business on July 15, 2009. , , ... an 11 percent increase earlier this year - and was again named ...
... , CHICAGO, June 12 ... driven by the eastern federal states.,This is in large ... potential despite the economic crisis. American investor interest in,Germany ... and Nordex AG shared their success stories at the ...
... OWINGS MILLS, Md., June 12 Medifast, Inc. (NYSE: ... the build out of new corporate-owned Medifast Weight Control Centers. ... more conservative in the build out, and analyze the success ... strong success, the Company will be expanding its investment in ...
... , Travelers Turn to InsureMyTrip.com for Coverage Protection and ... Stating ,the scientific criteria for an influenza pandemic have ... declared the A(H1N1) virus, commonly referred to as Swine ... http://www.newscom.com/cgi-bin/prnh/20070529/NETU076LOGO ) , , "Particularly ...
... of Medicine of the University of Southern California (USC) ... blood cells to breakan occurrence that marks the first ... study provides researchers with the clearest insight yet into ... in the chromosome, says principal investigator Michael R. Lieber, ...
Cached Medicine News:Health News:IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS 2Health News:IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS 3Health News:American Investors Highlight Successes in Eastern Germany 2Health News:Medifast, Inc. to Expand Investment in Corporate Medifast Weight Control Centers 2Health News:Medifast, Inc. to Expand Investment in Corporate Medifast Weight Control Centers 3Health News:World Health Organization Declares A(H1N1) Pandemic 2Health News:World Health Organization Declares A(H1N1) Pandemic 3Health News:USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma 2
... The Bledsoe Lever Lock Knee ... quick extension lock of the arthroscopic ... to allow motion for rehabilitation or ... quickly locked "rigidly" in full extension ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... The knee is the ... joint. Repetitive or inappropriate stresses ... often lead to excessive strain. ... the knee joint and activates ...
... knee brace provides maximum support ... of sports and activities. Geared ... pads to support medial and ... and hyperextension stop. 3/16" thick, ...
Medicine Products: